When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Medexus Pharmaceuticals press release (OTCQX:MEDXF): Q4 Revenue of $20.3M (+15.3% Y/Y) beats by $1.54M. Achieved adjusted EBITDA of $1.1M in fiscal Q4 2022 compared to -$1.6M in fiscal Q4 2021 and $1.9M in fiscal Q3 2022. Generated adjusted net loss of $4.6M in fiscal Q4 2022 and $24.0M in fiscal year 2022 compared to $5.2M in fiscal Q4 2021 and $7.6M in fiscal year 2021. Cash and cash equivalents of $10.0M (with $11.2M of total available liquidity) at end of fiscal Q4 2022.